Thursday, August 27, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

crispr

5 stories tagged "crispr"

Investigations

A Chinese Registry Marked the Trial 'Complete.' It Never Mentioned the Boy Who Died.

A boy died in a Chinese gene-therapy trial in August 2025. Months later the registry marked the study 'complete' and never mentioned him. He is one of three deaths now pulling Congress toward the trial data U.S. drugmakers ship home from China, while American inspectors almost never see the sites th

Drugs & FDA

The FDA Cleared a CRISPR Cure for Two-Year-Olds Whose Own Trial Enrolled No One That Young

Casgevy's pediatric trials enrolled 11 children aged five and up, yet the FDA extended the $2.2 million therapy down to age two, where the conditioning chemo can permanently sterilize a child too young to bank eggs or sperm.

Cancer

The Reason Immunotherapy Bounces Off Prostate Cancer: Tumors Chew Off a Genetic Tail to Blind the Immune System

Prostate tumors overproduce a protein that destroys the immune system's docking targets. A CRISPR tool that blocks the trick made checkpoint drugs work again, so far only in mice.

Investigations

A Gene-Editing Trial Killed a Six-Year-Old. The Only Official Penalty Was a $3,500 Fine.

Xinhua Hospital paid about 24,000 yuan in September 2025. The death it was fined over stayed out of the medical literature for another ten months, and out of the Nature paper entirely.

Drugs & FDA

The FDA Cleared a Sickle-Cell Cure for Two-Year-Olds in 53 Days. It Starts With Chemo That Can Sterilize Them.

Casgevy is a real advance against a brutal disease. It is also a $2.2 million therapy that requires sterilizing chemotherapy, saw a child die in trials, and reached toddlers on a 53-day review Makary's FDA hands out as a favor.